Experience

Davis Polk is advising IHS Markit on its all-stock merger with S&P Global that values IHS Markit at an enterprise value of $44 billion. Under the terms of the merger agreement, each…

Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…

We are advising VF on its acquisition

Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc. and related Eligen SNAC royalty stream obligations owed to MHR Fund Management LLC,…

Davis Polk is advising Cboe Global Markets on its acquisition of BIDS Trading, a registered broker-dealer and the operator of the BIDS Alternative Trading System. The transaction is…

Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc. Emerson, headquartered in St. Louis, Missouri, is a global technology and…

Davis Polk is advising Dufry AG in connection with its proposed acquisition of all the equity interests in Hudson Ltd. it does not already own for $7.70 in cash per Hudson Class A share…

Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725 million in cash. Total payments to Corvidia Therapeutics shareholders…

Davis Polk advised Dean Foods Company on the sale of substantially all of Dean Foods’s assets and business operations pursuant to Section 363 of the Bankruptcy Code to six third party…

Davis Polk is advising Varagon Capital Partners, L.P. on its agreement to form a new strategic partnership with Aflac Global Investments and the extension of its existing strategic…